semaglutide sglt2 inhibitor Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application SGLT2 Inhibitors vs. GLP-1 Agonists

The accelerated aging phenotype: the role of race and social determinants of health on aging

Monitoring Your Progress Keep records of your weight, measurements, energy levels, and any side effects when using Retatrutide

Cardiovascular benefits documented in the SUSTAIN-6 outcome trial

We are learning that more aggressive treatment of what we considered borderline or even normal levels of glucose and blood pressure in the past are giving us improved obstetric outcomes during pregnancy

This unique mechanism enhances ATP production and reduces the generation of reactive oxygen species (ROS), thereby mitigating oxidative stressa key factor in neuronal damage

This treatment has minimal side effects with little to no interference with patients daily activities